FX.co ★ New Zealand Stocks Rise for 2nd Session

The S&P/NZX 50 index increased by 0.7% to reach 12,577 at the close of trading on Thursday, marking its second consecutive day of gains and hitting its highest point in over a week. The growth was primarily driven by the healthcare sector, with notable performances from Ebos Group, which advanced by 3.2%, Ryman Healthcare, which surged by 6.3%, and Summerset, which rose by 1.4%. The property sector also contributed significantly, with Investore Property rising by 3.6%, Argosy Property by 2.9%, Property for Industry by 1.65%, Kiwi Property by 1.1%, and Precinct Properties by 0.85%. This market rally occurred despite a recent OECD report forecasting a slowdown in global economic growth from 3.3% in 2024 to 2.9% in 2025 and 2026. In its analysis of New Zealand, the OECD highlighted that while an economic recovery is underway, the nation remains susceptible to challenges in global trade. Investors also remained attentive to international developments, especially regarding US President Donald Trump's tariff strategies and the potential for dialogue between Trump and Chinese President Xi Jinping.